Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6602378.pdf
Reference37 articles.
1. Bajorin DF, McCaffrey JA, Dodd PM, Hilton S, Mazumdar M, Kelly WK, Herr H, Scher HI, Icasiano E, Higgins G (2000) Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules. Cancer 88: 1671–1678
2. de Wit R (2003) Overview of bladder cancer trials in the European Organisation for Research and Treatment. Cancer 97(Suppl 8): 2120–2126
3. Dimopoulos MA, Bakoyannis C, Georgoulias V, Papadimitriou C, Manolopoulos LA, Deliveliotis C, Karayannis A, Varkarakis I, Aravantinos G, Zervas A, Pantazopoulos D, Foutzilas G Bamias A, Kyriakakis Z, Anagnostopoulos A, Giannopoulos A, Kosmidis P (1999) Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicentre phase II study of the Hellenic Cooperative Oncology Group. Ann Oncol 10: 1385–1388
4. Dreicer R, Gustin DM, See WA, Williams RD (1996) Paclitaxel in advanced urothelial carcinoma: its role in patients with renal insufficiency and as salvage therapy. J Urol 156: 1606–1608
5. Dreicer R, Manola J, Roth BJ Cohen MB, Hatfield AK, Wilding G (2000) Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group Study. J Clin Oncol 18: 1058–1061
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand?;Biomedicines;2024-02-26
2. Gemcitabine/Nab‐Paclitaxel versus Gemcitabine/Carboplatin for Advanced Urothelial Carcinoma;BJU International;2023-11-27
3. Metastatic Carcinoma Urinary Bladder, Adjuvant Treatment and Follow-Up;A Guide to Management of Urological Cancers;2023
4. Bilateral nephrolithiasis and upper tract transitional cell carcinoma in horseshoe kidney;Current Urology;2022-09-08
5. Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study;Current Oncology;2022-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3